Travoprost Ophthalmic Solution
Product Images NDC 42571-130

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Travoprost Ophthalmic (NDC 42571-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Travoprost Figa

FDA Label Image

Travoprost Figb

FDA Label Image

Travoprost Figc

FDA Label Image

Travoprost Lbla

Travoprost Lbla
This is a prescription medication with NDC code 42571-130-27. Each milliliter of the solution contains 0.04 mg of Fravoprost. It should be stored at a temperature range of 2°C to 25°C (36°F to 77°F). It is a Travoprost Ophthalmic Solution used for the eyes only. Manufactured by Micro Labs USA, Inc., the medication comes in a buffered solution. The document also mentions the manufacturing information and a revision date of 01/2022.*
FDA Label Image

Travoprost Lblb

Travoprost Lblb
NDC 42571-130-21 is a prescription-only medication that contains 0.04 mg of travoprost, USP per mL. It is a solution for use in the eyes only and is manufactured by M.L. in India. The medication is stored at a temperature of 2° to 25°C. The dosage information is available in the insert. The ionic-buffered solution is made by Micro Labs Limited and is for use in the eyes only. The medication is manufactured for Micro Labs USA, Inc. in Somerset, NJ, and the revision date is January 2022.*
FDA Label Image

Structure (Travoproststructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.